Gene Review:
PPIG - peptidylprolyl isomerase G (cyclophilin G)
Homo sapiens
Synonyms:
CARS-Cyp, CARS-cyclophilin, CASP10, CYP, Clk-associating RS-cyclophilin, ...
- Genetic variability of the CYP 2D6 gene is not a risk factor for sporadic Parkinson's disease. Diederich, N., Hilger, C., Goetz, C.G., Keipes, M., Hentges, F., Vieregge, P., Metz, H. Ann. Neurol. (1996)
- Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis. Huang, Y.S., Chern, H.D., Su, W.J., Wu, J.C., Chang, S.C., Chiang, C.H., Chang, F.Y., Lee, S.D. Hepatology (2003)
- Retroviral transfer of human cytochrome P450 genes for oxazaphosphorine-based cancer gene therapy. Jounaidi, Y., Hecht, J.E., Waxman, D.J. Cancer Res. (1998)
- Export of a heterologous cytochrome P450 (CYP105D1) in Escherichia coli is associated with periplasmic accumulation of uroporphyrin. Akhtar, M.K., Kaderbhai, N.N., Hopper, D.J., Kelly, S.L., Kaderbhai, M.A. J. Biol. Chem. (2003)
- Cyclophilin D as a drug target. Waldmeier, P.C., Zimmermann, K., Qian, T., Tintelnot-Blomley, M., Lemasters, J.J. Current medicinal chemistry. (2003)
- Expression of cytochrome P450 mRNAs in the colon and the rectum in normal human subjects. Mercurio, M.G., Shiff, S.J., Galbraith, R.A., Sassa, S. Biochem. Biophys. Res. Commun. (1995)
- Non-Michaelis-Menten kinetics in cytochrome P450-catalyzed reactions. Atkins, W.M. Annu. Rev. Pharmacol. Toxicol. (2005)
- Mechanisms of aflatoxin carcinogenesis. Eaton, D.L., Gallagher, E.P. Annu. Rev. Pharmacol. Toxicol. (1994)
- Association of the expression of an SR-cyclophilin with myeloid cell differentiation. Giardina, S.L., Coffman, J.D., Young, H.A., Potter, S.J., Frey, J.L., Ortaldo, J.R., Anderson, S.K. Blood (1996)
- Albumin adducts of benzene oxide and 1,4-benzoquinone as measures of human benzene metabolism. Rappaport, S.M., Waidyanatha, S., Qu, Q., Shore, R., Jin, X., Cohen, B., Chen, L.C., Melikian, A.A., Li, G., Yin, S., Yan, H., Xu, B., Mu, R., Li, Y., Zhang, X., Li, K. Cancer Res. (2002)
- CYP1A in TCDD toxicity and in physiology-with particular reference to CYP dependent arachidonic acid metabolism and other endogenous substrates. Rifkind, A.B. Drug Metab. Rev. (2006)
- Metabolism of the soyabean isoflavone daidzein by CYP1A2 and the extra-hepatic CYPs 1A1 and 1B1 affects biological activity. Atherton, K.M., Mutch, E., Ford, D. Biochem. Pharmacol. (2006)
- Nicotine induces brain CYP enzymes: relevance to Parkinson's disease. Miksys, S., Tyndale, R.F. J. Neural Transm. Suppl. (2006)
- Influence of chronic renal failure on stereoselective metoprolol metabolism in hypertensive patients. Cerqueira, P.M., Coelho, E.B., Geleilete, T.J., Goldman, G.H., Lanchote, V.L. Journal of clinical pharmacology. (2005)
- Genetic polymorphism of CYP2A6 as one of the potential determinants of tobacco-related cancer risk. Kamataki, T., Fujieda, M., Kiyotani, K., Iwano, S., Kunitoh, H. Biochem. Biophys. Res. Commun. (2005)
- Over-expression of SR-cyclophilin, an interaction partner of nuclear pinin, releases SR family splicing factors from nuclear speckles. Lin, C.L., Leu, S., Lu, M.C., Ouyang, P. Biochem. Biophys. Res. Commun. (2004)
- The human nuclear SRcyp is a cell cycle-regulated cyclophilin. Dubourg, B., Kamphausen, T., Weiwad, M., Jahreis, G., Feunteun, J., Fischer, G., Modjtahedi, N. J. Biol. Chem. (2004)
- A novel polymorphic cytochrome P450 formed by splicing of CYP3A7 and the pseudogene CYP3AP1. Rodriguez-Antona, C., Axelson, M., Otter, C., Rane, A., Ingelman-Sundberg, M. J. Biol. Chem. (2005)
- A novel human cytochrome P450 gene (P450IIB): chromosomal localization and evidence for alternative splicing. Miles, J.S., Spurr, N.K., Gough, A.C., Jowett, T., McLaren, A.W., Brook, J.D., Wolf, C.R. Nucleic Acids Res. (1988)
- Mutagenic activation of environmental carcinogens by microsomes of gastric mucosa with intestinal metaplasia. Tatemichi, M., Nomura, S., Ogura, T., Sone, H., Nagata, H., Esumi, H. Cancer Res. (1999)
- A peptidyl-prolyl cis/trans-isomerase (cyclophilin G) in regulated secretory granules. Takaki, Y., Muta, T., Iwanaga, S. J. Biol. Chem. (1997)
- Metabolism of rifabutin in human enterocyte and liver microsomes: kinetic parameters, identification of enzyme systems, and drug interactions with macrolides and antifungal agents. Iatsimirskaia, E., Tulebaev, S., Storozhuk, E., Utkin, I., Smith, D., Gerber, N., Koudriakova, T. Clin. Pharmacol. Ther. (1997)
- Production of reactive oxygen species by microsomes enriched in specific human cytochrome P450 enzymes. Puntarulo, S., Cederbaum, A.I. Free Radic. Biol. Med. (1998)
- The genetic polymorphism of debrisoquine/sparteine metabolism-molecular mechanisms. Meyer, U.A., Skoda, R.C., Zanger, U.M. Pharmacol. Ther. (1990)
- A drug interaction between zafirlukast and theophylline. Katial, R.K., Stelzle, R.C., Bonner, M.W., Marino, M., Cantilena, L.R., Smith, L.J. Arch. Intern. Med. (1998)
- Dose escalation or immediate full dose when switching from efavirenz to nevirapine-based highly active antiretroviral therapy in HIV-1-infected individuals? Winston, A., Pozniak, A., Smith, N., Fletcher, C., Mandalia, S., Parmar, D., Gibbons, S., Back, D., Gazzard, B., Nelson, M. AIDS (2004)
- Ethanol and production of the hepatotoxic metabolite of acetaminophen in healthy adults. Thummel, K.E., Slattery, J.T., Ro, H., Chien, J.Y., Nelson, S.D., Lown, K.E., Watkins, P.B. Clin. Pharmacol. Ther. (2000)
- Moclobemide, a substrate of CYP2C19 and an inhibitor of CYP2C19, CYP2D6, and CYP1A2: a panel study. Gram, L.F., Guentert, T.W., Grange, S., Vistisen, K., Brøsen, K. Clin. Pharmacol. Ther. (1995)
- Role of cytochrome P450 in phospholipase A2- and arachidonic acid-mediated cytotoxicity. Caro, A.A., Cederbaum, A.I. Free Radic. Biol. Med. (2006)
- Induction of CYP2E1 activity in liver transplant patients as measured by chlorzoxazone 6-hydroxylation. Burckart, G.J., Frye, R.F., Kelly, P., Branch, R.A., Jain, A., Fung, J.J., Starzl, T.E., Venkataramanan, R. Clin. Pharmacol. Ther. (1998)
- Transcript profiling of enzymes involved in detoxification of xenobiotics and reactive oxygen in human normal and simian virus 40 T antigen-immortalized oral keratinocytes. Vondracek, M., Weaver, D.A., Sarang, Z., Hedberg, J.J., Willey, J.C., Wärngård, L., Grafström, R.C. Int. J. Cancer (2002)
- CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer. Silvestri, L., Sonzogni, L., De Silvestri, A., Gritti, C., Foti, L., Zavaglia, C., Leveri, M., Cividini, A., Mondelli, M.U., Civardi, E., Silini, E.M. Int. J. Cancer (2003)
- Metabolic activation of pradefovir by CYP3A4 and its potential as an inhibitor or inducer. Lin, C.C., Fang, C., Benetton, S., Xu, G.F., Yeh, L.T. Antimicrob. Agents Chemother. (2006)